The Texas Innovation Conference & Awards serves as a vital platform for strengthening Texas’s innovation ecosystem by showcasing outstanding researchers whose work accelerates commercialization, fuels startup creation, and fosters meaningful partnerships between academia and industry. The University Innovator category specifically identifies individuals who have demonstrated measurable progress in bridging the gap between laboratory research and real-world applications, thereby contributing to regional and national economic growth and public welfare.

Among the esteemed UTSA honorees is Dr. Lyle Hood, an associate professor of mechanical engineering whose work has revolutionized airway management technologies in emergency and combat care environments. Through the Medical Design Innovations Laboratory under his leadership, Hood has engineered a suite of portable suction devices specifically designed for diverse prehospital and aeromedical evacuation scenarios. These innovations are characterized by their lightweight design and unwavering reliability, addressing critical challenges faced by first responders in the field.

Dr. Hood’s research portfolio also includes the design and development of next-generation endotracheal tubes aimed at improving intubation success under extreme and high-pressure conditions. His designs were guided by extensive early end-user engagement, encompassing hundreds of clinicians and medics to ensure that engineering solutions effectively meet practical needs encountered during emergency interventions. This collaborative approach has culminated in the launch of EmergenceMed LLC, a UTSA-backed startup devoted to commercializing these critically important medical technologies. His efforts have attracted over $3 million in competitive funding from federal and private sources, simultaneously mentoring a pipeline of more than 100 student innovators.

Equally transformative is the work of Dr. Amina Qutub, the Burzik Endowed Professor of Engineering Design and associate professor in biomedical engineering, whose research integrates artificial intelligence with precision medicine to enhance healthcare delivery. Dr. Qutub spearheads the MATRIX AI Consortium, a cutting-edge collaborative initiative dedicated to advancing AI applications in biomedical research. She also co-directs the Center for Precision Medicine, further consolidating UTSA’s leadership in this interdisciplinary frontier.

Dr. Qutub’s research is situated at the confluence of computer science, biology, and engineering, where she has co-founded two innovative biotech startups: PaloBio and Leah. PaloBio develops sophisticated digital advocates to assist individuals with atypical neurological disorders, while Leah leverages AI to improve trauma care outcomes. She leads the ambitious BEACON project, a state-level initiative aimed at transforming trauma and stroke care by providing real-time AI decision support and recovery tools. This project is a product of the iRemedyACT Consortium, which unites more than thirty clinicians, AI scientists, and biomedical engineers across seven university hospitals, enabling the development of AI-driven data infrastructure to reduce emergency care delays.

Additionally, Dr. Qutub directs the Quantu Project, a nationwide longitudinal study that combines biosensing technology with neurogenesis assays to optimize brain health throughout the human lifespan. Her innovative work has earned numerous accolades, including a fellowship in the American Institute for Medical and Biological Engineering, the National Academies Keck Future Initiatives award, and a National Science Foundation CAREER award. In 2025, she will represent U.S. scientific innovation as a Department of State Overseas Speaker on the “AI in Innovation” tour, further amplifying the international reach and impact of her research.

Addressing the burgeoning mental health crisis, Dr. David L. Roberts, associate professor of psychiatry, was recognized for his groundbreaking platform, Reflective Training (RT), which fundamentally reshapes psychotherapy training. Faced with a critical shortage of qualified behavioral health professionals, Dr. Roberts developed RT as an innovative web-based system that replaces traditional lecture models with dynamic and scalable experiential learning methods. RT employs structured role-playing exercises combined with actionable feedback, promoting a performance science approach that enables advanced trainees to become coaches, thereby mitigating the burden on scarce expert faculty.

RT has been integrated successfully into UTSA’s medical education programs, including a notable initiative where student leaders train peers to deliver counseling skills in residential substance use treatment centers. Research validating RT’s effectiveness found that counseling interns trained through this model perform on par with licensed clinicians in crisis intervention, resulting in significant cost savings—close to $300,000 over two years for Bexar County. To expand the platform’s reach, Dr. Roberts co-founded Reflective Learning Inc., which currently supports clinical onboarding and quality assurance across multiple UT clinics as well as community agencies throughout Texas.

The RT platform has also been adopted by Communities in Schools, where 60 school counselors use it to impart emotion regulation skills, and by the Haven for Hope homeless services campus, serving all Bexar County, to enhance crisis counseling staff training. Beyond RT, Dr. Roberts is renowned for developing Social Cognition and Interaction Training (SCIT), a therapeutic approach for individuals with schizophrenia that is implemented by over 3,000 clinicians in eight countries, further demonstrating his impact on mental health treatment paradigms.

Together, these three UTSA researchers exemplify the university’s commitment to harnessing academic excellence for societal benefit. Their interdisciplinary efforts span mechanical engineering, artificial intelligence, biomedical innovation, and psychiatric care—collectively addressing some of the most urgent healthcare challenges of our time. The successful commercialization of their technologies and their active engagement with industry and clinical partners exemplify the high-impact potential of academic research when coupled with entrepreneurial vision and community collaboration.

The inaugural Texas Innovation Award not only honors these researchers but also highlights the essential role of state-supported programs in fostering an ecosystem where scientific discovery translates into real-world improvements. Their work epitomizes the fusion of rigorous scientific inquiry with practical innovation, resulting in medical devices that save lives, AI systems that enhance critical decision-making, and scalable mental health platforms that expand access to quality care.

UTSA’s rapidly evolving research enterprise serves as a beacon of how universities can serve as powerhouses for technology transfer and innovation-driven economic development. The university’s holistic approach—from bench to bedside, and from prototype to startup—demonstrates how strategically supported translational research infrastructure can fuel breakthroughs that meet complex healthcare needs with scalable and sustainable solutions.

As the recipients continue to lead transformative projects, their collective impact is poised to elevate Texas as a global leader in health-related technological innovation. Advances such as portable airway management systems, AI-enabled trauma care, and scalable psychotherapy training platforms herald a new era of integrated, technology-powered healthcare solutions that hold promise for improving patient outcomes and system efficiencies worldwide.

In sum, the Texas Innovation Award shines a spotlight on the critical contributions of Drs. Hood, Qutub, and Roberts, who have successfully intertwined engineering, artificial intelligence, and psychiatry into innovative tools and platforms. Their pioneering work not only enhances lives in Texas but also charts pathways for future breakthroughs in emergency medicine, neurological disorders, trauma care, and mental health treatment on a national and international stage.

Subject of Research: Translational innovations in emergency medical devices, AI-driven healthcare solutions, and scalable mental health training platforms.

Article Title: UT San Antonio Researchers Earn Texas Innovation Award for Revolutionary Advances in Medical Technology and AI

News Publication Date: April 24, 2024

Web References:

• UTSA Medical Design Innovations Laboratory
• EmergenceMed LLC
• MATRIX AI Consortium
• Center for Precision Medicine
• Reflective Training Platform

Image Credits: UT San Antonio

Keywords

Emergency Medicine, Artificial Intelligence, Biomedical Engineering, Mental Health, Medical Devices, Trauma Care, Translational Research, Innovation, Health Technology, Behavioral Health Training, Precision Medicine, Startup Ecosystem

This multimillion-dollar award reflects an integration of federal funding and institutional contributions from both the University of Cincinnati (UC) and Cincinnati Children’s, collectively amassed to surpass $65 million in total investment towards the CCTST. Since its establishment in 2005, the CCTST has been a cornerstone for fostering translational research within UC’s Academic Health Center, reflecting nearly two decades of commitment to accelerating scientific breakthroughs that revolutionize patient care.

Translational science endeavors to bridge fundamental research and patient-oriented outcomes, transforming biomedical insights into efficacious diagnostics, therapeutics, and preventive strategies. Over the past years, the CCTST has supported more than 8,000 investigators and trainees, fostering an environment rich in interdisciplinary collaboration and cutting-edge innovation. This extensive network accelerates the journey from bench to bedside, ensuring that scientific advancements translate swiftly and effectively into improved health outcomes.

The recent funding award is more than a financial boost—it is a reaffirmation of the synergistic partnership between two of the region’s foremost medical institutions, the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital. Gregory C. Postel, MD, dean of the College of Medicine and UC’s executive vice president for health affairs, highlights the award’s significance, noting that it will enhance the center’s capacity to mobilize clinical and translational research, deepen community engagement, and address pressing public health challenges with innovative precision.

A key evolution envisioned in this funding cycle is the transformation of the CCTST into an integrated Clinical and Translational Learning System (CTLS). This system aims to streamline the discovery-to-implementation pipeline by fostering an ecosystem where researchers, clinicians, trainees, and community stakeholders collaborate seamlessly. The CTLS framework will harness data analytics, translational methodologies, and educational initiatives to shorten the lag between scientific discovery and clinical application.

The impact of this award extends beyond infrastructural support. Per Dr. Tina Cheng, chief medical officer and chair of pediatrics at Cincinnati Children’s, the investment underpins the critical infrastructure that sustains high-caliber medical research. This infrastructure facilitates rigorous study designs, robust biostatistical analysis, and effective community-based partnership models—all essential to rendering research findings actionable, lessons that lead to improved health for both pediatric and adult populations.

Strategic priorities for the next seven years include refining research methodologies, enhancing collaborative networks among scientists and community entities, and ensuring rapid dissemination and implementation of innovations. The program’s expansion will entail advanced training curricula for emerging researchers, embedding precision health approaches designed to address complex public health issues, as well as robust development of safe, efficient, and patient-centered research systems.

The CCTST’s unique infrastructure offers an unparalleled platform for interdisciplinary research, augmenting translational efforts across diverse medical disciplines. Brett Kissela, MD, executive vice dean at the UC College of Medicine, emphasizes the center’s national leadership role and its capacity to convert foundational discoveries into tangible therapies and interventions with measurable clinical benefits. This leadership is critical to maintaining the momentum of biomedical innovation in a highly competitive research environment.

Guided by experienced co-directors including Jareen Meinzen-Derr, PhD, Achala Vagal, MD, and Jeffrey Strawn, MD, the center harnesses a broad coalition of over 40 faculty and staff from both UC and Cincinnati Children’s. Their collective expertise spans biostatistics, radiology, psychiatry, and translational science administration, ensuring a comprehensive, multidisciplinary approach to research facilitation and grant stewardship.

The co-directors articulate a vision centered on delivering an integrated clinical and translational learning system that empowers all stakeholders—from scientists to community members—to contribute to a dynamic knowledge exchange. This vision fosters resilience in translational pipelines and ensures that scientific advancements truly result in improved lives across demographic boundaries.

In an era where public health concerns demand swift and effective responses, the CCTST stands out as a beacon of innovation and collaboration. Its renewed funding will accelerate vital translational research that targets critical health challenges, embodying the NIH’s mission to make science matter through improved health outcomes and reduced health disparities.

The CCTST’s model of combining cutting-edge research technologies, comprehensive training programs, and extensive community engagement programs sets a standard in biomedical research infrastructure nationwide. Deploying the Clinical and Translational Learning System will reinforce the center’s ability to deliver personalized, precision health interventions powered by data-driven insights, thereby catalyzing a new epoch of medical breakthroughs.

With this renewed seven-year commitment, the University of Cincinnati and Cincinnati Children’s are positioned to lead the next wave of translational science innovation. Their integrated approach promises significant improvements in clinical trial design, participant recruitment, and data integration across research domains — all crucial to expediting the delivery of novel therapeutic solutions to patients in urgent need.

Subject of Research: Clinical and Translational Science, Biomedical Research Infrastructure, Precision Health, Research Training, Public Health Innovation

Article Title: University of Cincinnati and Cincinnati Children’s Secure $37.2 Million NIH Award to Propel Clinical and Translational Science into a New Era

News Publication Date: Not provided

Web References: Not provided

References: Not provided

Image Credits: Not provided

Keywords: Biomedical research funding, Human health